Money /
Money News
Related Topics:
Banking & finance
Banking & finance
TCM firms eye Hong Kong IPOs to fuel global expansion
Over the past year, 34 innovation and technology, life and health science companies set up or expanded their operations in Hong Kong.
8 Jan 2026 - 7:54PM
Made in China 2025
Chinese biotechs strike a record US$136 billion in out-licensing deals in 2025
8 Jan 2026 - 8:30AM
Made in China 2025
Meow or never: China’s pudgy pets spark race for weight-loss drugs
7 Jan 2026 - 8:30AM
Banking & finance
Citic Securities claims top spot in Asia-Pacific investment banking for 2025
Chinese rivals fill out the rest of the top five, while US bank Morgan Stanley comes in sixth.
6 Jan 2026 - 8:56PM
Citic claimed the crown as the top bookrunner for Asia-Pacific-issued bonds with 6 per cent market share. Photo: Shutterstock Images
Banking & finance
The ‘biology winter’ thaws: why investors are buying Hong Kong’s biotech IPOs
A wave of China out-licensing deals is feeding a biotech comeback in Hong Kong, where IPOs and follow-on placements are surging.
5 Jan 2026 - 11:08AM
IPO
China vital to Insilico’s plan to build biotech’s AI ‘Einstein’ for new drugs
US firm, backed by Fosun and Tencent, expands research base in China as it develops an AI-powered drug-discovery tool.
31 Dec 2025 - 2:26PM
Advertisement
Advertisement
Advertisement
Made in China 2025
China’s rising biotech clout on show in flurry of billion-dollar licensing deals
A burst of overseas licensing pacts is spotlighting China’s biotech sector, as Jacobio, Coherent Biopharma and Harbour BioMed land deals.
26 Dec 2025 - 10:47AM
The latest transactions reflect a broader pattern of multinational drugmakers turning to Chinese biotechs for pipeline replenishment. Photo: Shutterstock
Swire Group
Swire Pacific’s Guy Bradley to lead Hong Kong’s Cathay Pacific, Swire Coca-Cola
Bradley succeeds Patrick Healy, who will retire from the Swire Group in May next year after over three decades of service.
23 Dec 2025 - 10:19PM
Banking & finance
Global firms turn to M&A in EVs and biotech to deepen China investment: KPMG
Survey of multinational corporations finds optimism in life sciences, healthcare and manufacturing, with half forecasting revenue growth.
23 Dec 2025 - 9:30AM
Banking & finance
Gold takes centre stage as Hong Kong builds commodities ecosystem
Hong Kong plans to build an international gold trading centre as part of a wider commodities hub push.
22 Dec 2025 - 7:15PM
United States
Are Chinese biotechs what the doctor ordered as Big Pharma faces ‘patent cliff’?
US drug makers are racing to plug looming ‘patent cliff’ revenue gaps – and increasingly they are turning to China biotechs.
20 Dec 2025 - 8:57AM
US drugmakers are increasingly looking to Chinese biotechs as an answer to the revenue gaps left by the looming ‘patent cliff’. Illustration by Henry Wong
Banking & finance
Chinese AI, chip start-ups court global investors with Hong Kong listing plans
GigaDevice and Montage are each aiming to raise as much as US$1 billion from Hong Kong listings as early as January, report says.
19 Dec 2025 - 4:30PM
Mergers & Acquisitions
Chinese brokerage CICC unveils merger details with Dongxing, Cinda
The three-way merger will create China’s fourth-largest investment bank with assets of US$128 billion.
18 Dec 2025 - 5:30PM
MetaX
MetaX stock soars 700% in Shanghai debut as traders snap up Chinese GPU maker
MetaX closes at 829.90 yuan on Wednesday, from its IPO price of 104.66 yuan, after gaining as much as 755 per cent in intraday trading.
17 Dec 2025 - 4:45PM
Made in China 2025
China’s new drug insurance: lifeline for patients or squeeze on big firms?
New insurance formulary trims costs of Alzheimer’s and cancer therapies and marks a small win for global novel drug makers.
17 Dec 2025 - 7:30AM
The commercial insurance formulary covers some medicines that are not yet eligible for reimbursement under the country’s National Reimbursement Drug List. Photo: Shutterstock
Made in China 2025
Chinese biotech Scizeng’s global licensing deal to yield up to US$1.44 billion
Yarrow Bioscience gets exclusive global rights for the GenSci098 therapy to treat thyroid eye disease and Graves’ disease.
16 Dec 2025 - 3:47PM
Banking & finance
Six major Hong Kong banks keep prime rates unchanged despite HKMA base rate cut
Savings rates near zero limit room for cuts as lenders protect profitability margins, analysts say.
11 Dec 2025 - 5:55PM
4
Advertisement
Advertisement
Advertisement
Made in China 2025
China’s Fosun Pharma unit strikes US$2.1 billion obesity drug deal with Pfizer
Yao Pharma’s deal with the US pharmaceutical giant underscores China’s growing role in global biotech licensing.
10 Dec 2025 - 4:39PM
The collaboration is “another significant milestone in Fosun Pharma’s strategy of innovation and internationalisation”, according to the company. Photo: Reuters
Banking & finance
Hong Kong launches HKEX Tech 100 Index in pivot towards innovation-driven growth
Unveiling of benchmark tracking Hong Kong-listed tech firms comes amid a wave of property stock delistings.
9 Dec 2025 - 5:51PM
IPO
Exclusive
|
Meet the Illinois farmer sowing the seeds of the world’s biggest IPOs of 2026
Jeff Rowe, a fifth-generation Illinois farmer, runs a Chinese-owned Swiss company in Basel that is aiming for one of the world’s largest IPOs in Hong Kong, due in 2026.
6 Dec 2025 - 11:18AM
China stock market
Moore Threads shares dazzle with fivefold jump in Shanghai debut
Moore’s shares began trading at 650 yuan amid a declining market, a 468 per cent jump from their initial public offering price of 114.28 yuan.
5 Dec 2025 - 4:37PM
Banking & finance
Emerging markets to outperform US stocks as dollar weakness continues: report
Latin America, which has been an underappreciated market for many years, is the stand-out performer in emerging markets.
10 Dec 2025 - 5:59PM
A trader at work on the floor of the New York Stock Exchange, November 19, 2025. Photo: Reuters
Millionaires and billionaires
Mainland China’s billionaire count surges as BYD and Mixue bosses power gains
The combined wealth of mainland China’s billionaires soars 22 per cent to US$1.77 trillion; Hong Kong’s ultra-rich population rises.
4 Dec 2025 - 5:29PM
Banking & finance
Hong Kong’s investment body posts US$300 million income in first year
Every dollar invested by the HKIC has attracted more than six in long-term market capital, Financial Secretary Paul Chan says.
4 Dec 2025 - 10:05AM
Banking & finance
China’s JD.com unit Jingdong Industrials aims for US$412 million Hong Kong IPO
Seven cornerstone investors led by London-based M&G Investments pledge a total of US$170 million.
3 Dec 2025 - 3:14PM
Help preserve 120 years of quality journalism.
SUPPORT NOW
